Marqibo Chemotherapy Information

A type of chemotherapy, Marqibo® (liposomal vincristine sulfate) is used to treat Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) in adults. It is used when at least two other treatments have been tried and the cancer has returned or become worse.
 
Marqibo is administered by a healthcare provider in a healthcare setting. It comes as an injection that is given intravenously (by IV) once every seven days. It is common for people to develop some type of side effect during treatment, such as constipation, nausea, or fatigue.
 
For many people, Marqibo may be an effective form of chemotherapy; however, not everyone can use this drug. Information on Marqibo should be reviewed with your healthcare provider before starting treatment to reduce your chances of developing potentially dangerous complications, such as nerve problems, intestinal blockage, or serious infections.
 
(Click Marqibo for more information, including other possible side effects and how this form of chemotherapy works.)
 
 

Marqibo Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.